NCT06025318

An Evaluation of the Effect of Food on the PK of a Novel PanCytoVir™ Suspension (100mg/ml), in Healthy, Adult Volunteers

An Open-label, Balanced, Randomized, Two-period, Crossover, Single Dose Study to Compare the Bioavailability of PanCytoVir™ Oral Suspension (100mg/ml), in Healthy, Adult, Human Subjects Under Fed and Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: TrippBio, Inc. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is an open-label, balanced, randomized, two-period, crossover, single dose study to compare the relative bioavailability in normal healthy, adult, human subjects under Fed and Fasting conditions. Subjects will receive a single oral dose of probenecid oral suspension (100 mg/mL) under fed and fasted conditions.

Conditions

• Relative Bioavailability

Interventions

Type	Name	Description
DRUG	PanCytoVir™	PanCytoVir™ 100 mg/mL oral suspension

Timeline

• Start date: 2024-09-01
• Primary completion: 2024-09-30
• Completion: 2024-10-15
• First posted: 2023-09-06
• Last updated: 2024-11-21

Locations

1 site across 1 country: India

Regulatory

• FDA-regulated drug study